Prevention of Secondary Infections by Interferon Gamma in ICU-acquired Sustained Immune-suppression

Clinical trial NCT06774235 · RECRUITING

Trial details

NCT number: NCT06774235
Sponsor: University Hospital, Limoges
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Sustained Immunosuppression

Start date: 2025-07-09
Primary completion: 2028-10-09
Enrollment: 326

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.